Cargando…
Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
In a recent issue of the BMC Psychiatry, the evidence of effectiveness of treatments for psychiatric conditions in end-stage cancer patients was reviewed (Johnson, 2018). The review was comprehensive, and included traditional and non-traditional/alternative treatments, including herbal medicines and...
Autores principales: | dos Santos, Rafael Guimarães, Bouso, José Carlos, Hallak, Jaime E. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816167/ https://www.ncbi.nlm.nih.gov/pubmed/31660905 http://dx.doi.org/10.1186/s12888-019-2288-z |
Ejemplares similares
-
Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
por: dos Santos, Rafael G., et al.
Publicado: (2020) -
The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2021) -
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature
por: Rocha, Juliana M., et al.
Publicado: (2019) -
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023) -
The Potential Role of Serotonergic Hallucinogens in Depression Treatment
por: Psiuk, Dominika, et al.
Publicado: (2021)